Company Rayont, Inc. Other OTC
Equities
RAYT
US75508M1009
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | Delta |
---|---|---|---|
Nutritional Supplements and Myotherapy
100.0
%
| 3 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | Delta |
---|---|---|---|
Australia
100.0
%
| 3 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 20-03-30 | |
Ilenna Copley
COO | Chief Operating Officer | - | 22-05-15 |
Dhurata Toli
BRD | Director/Board Member | 48 | 21-03-24 |
Paul Smith
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 22-04-20 |
Dhurata Toli
BRD | Director/Board Member | 48 | 21-03-24 |
Chief Executive Officer | 48 | 20-03-30 | |
Mark van Wyk
BRD | Director/Board Member | - | 22-04-20 |
Thea Dillon
BRD | Director/Board Member | - | 22-04-20 |
Bedri Thartori
CHM | Chairman | - | 23-02-22 |
Director/Board Member | - | 23-02-22 | |
Nara Chan
BRD | Director/Board Member | - | 23-02-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,163,797 | 24,169,968 ( 48.18 %) | 0 | 48.18 % |
Company contact information
Rayont, Inc.
228 Hamilton Avenue 3rd floor
94301, Palo Alto
+
Sector
1st Jan change | Capi. | |
---|---|---|
+17.09% | 44.63B | |
+42.10% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+44.11% | 14.06B | |
+32.33% | 12.54B | |
-7.26% | 11.28B |